For Health Care Professionals (HCPs) only.
If you are not a Heath Care Professional (HCP) please click here to view the homepage.
BPL recently participated at the International Society on Thrombosis and Haemostasis (ISTH) Congress (9-13 July 2022), where it sponsored a scientific presentation on rare bleeding disorder therapies during a product theatre targeted for healthcare professionals.
Achieving balance with Prophylaxis in Hereditary Factor X Deficiency –
Welcome & Introduction on evolution of diagnostic criteria & how does it look in 2022?Dr Jeanette Payne | MD
Consultant Paediatric Haematologist
Sheffield Children NHS Foundation Trust | Sheffield, UK
Managing Adults with hereditary Factor X deficiency – approach to prophylaxisDr Steven Austin | MD
Guy’s & St Thomas’ NHS Foundation Trust | London, UK
Managing Children with hereditary Factor X deficiency – approach to prophylaxisDr Catherine McGuinn | MD
Assistant Professor of Pediatrics + Director, Comprehensive Center for Hemophilia and Coagulation Disorders
Weill Cornell Medicine + Division of Pediatric Hematology Oncology | New York, USA
If you are experiencing difficulties in seeing this video, please contact your system administrator.
Summary of Products Characteristic
Factor X deficiency
Factor X deficiency is an inherited rare bleeding disorder.